Strategic Partnership Opportunity to co-sell or integrate Bio-Techne's R&D Systems instruments with Refeyn mass photometry platform to offer a combined solution for charge heterogeneity, molecular weight and aggregation analysis, appealing to proteomics and biopharma researchers seeking streamlined workflows.

Expansion Potential Target growth in contract research organizations and pharma manufacturing through the integrated technology offering, leveraging R&D Systems' existing instrument base and the recent Refeyn collaboration to drive adoption in high-precision protein analysis.

Analytics & Cloud Sell complementary cloud-based data analytics, telemetry, and remote monitoring capabilities (Google Cloud, analytics tools) to enhance instrument data workflows, reproducibility, and collaboration across labs.

Regulatory & Validation Highlight capabilities for robust quality control and ELISA-related assay development support, aligning with GMP/compliance interests for therapeutic antibody production and protein characterization.

Growth & Funding Leverage mid-market revenue and $98M funding background to approach growth-stage biotechs and CROs seeking scalable, proven protein analysis platforms; emphasize speed, precision, and four-hour streamlined workflows to justify investment.